Please find the attached Monitoring Agency report for the quarter ended on September 30, 2026.

KINGFA/SE/2026-27 Date: 06/11/2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G- Block, Phiroze Jeejeebhoy Towers, Dalal Street, Bandra –Kurla Complex, Bandra (East), Mumbai – 400001 Mumbai 400051 Symbol: KINGFA Scrip Code: 524019 Subject: Monitoring Agency Report for the quarter ended September 30, 2026. Dear Sir/Madam, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed herewith the Monitoring Agency Report with respect to the utilization of issue proceeds for the quarter ended September 30, 2026 issued by CARE Ratings Limited. We request you to take the above information on record. Thanking You, Yours faithfully For Kingfa Science & Technology (India) Limited Deepak Vyas Company Secretary & Compliance officer Kingfa Science & Technology (India) Limited CIN: L25209TN1983PLC010438 Regd. Office: Dhun Building, III Floor, 827, Anna Salai, Chennai - 600002. Tel: +44 – 28521736 Fax: +44 – 28520420 E-mail: cs@kingfaindia.com Website: www.kingfaindia.com No. CARE/ARO/GEN/2026-27/1222 The Board of Directors Kingfa Science & Technology (India) Limited Dhun Building, 3rd Floor, 827, Mount Road, Madras, Tamilnadu, India – 600002 November 06, 2026 Dear Sir, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the preferential issue of Kingfa Science & Technology India Limited (“the Company”) We write in our capacity of Monitoring Agency for the preferential issue for the amount aggregating to Rs.500 crore of the Company and refer to our duties cast under Regulation 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated September 08, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Jignesh Trivedi Associate Director Jignesh.trivedi@careedge.in Report of the Monitoring Agency Name of the issuer: Kingfa Science & Technology (India) Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Jignesh Trivedi Designation of Authorized person/Signing Authority: Associate Director 1) Issuer Details: Name of the issuer : Kingfa Science & Technology (India) Limited Name of the promoter : Kingfa Science & Technology Co. Ltd (KSTCL; Parent Company) Industry/sector to which it belongs : Industrials – Capital Goods – Industrial Products – Plastic Products Industrial 2) Issue Details Issue Period : Not applicable Type of issue (public/rights) : Preferential Issue Type of specified securities : Equity Shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs.500 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors CA Certificate* KSTIL utilized Rs.18.60 crore Whether all utilization is as per the disclosures in the Management Certificate Yes towards objects of the issue No comments Offer Document? Bank Statement during Q2FY27. Sample Invoices Whether shareholder approval has been obtained in CA Certificate* case of material deviations# from expenditures Not applicable Management Certificate Not applicable No comments disclosed in the Offer Document? Bank Statement Whether the means of finance for the disclosed objects No Management Certificate No No comments of the issue have changed? Management Certificate Is there any major deviation observed over the earlier No Monitoring Agency Report (dated No deviations observed No comments monitoring agency reports? August 14, 2026) Government/statutory approvals Government/statutory approvals (if Whether all Government/statutory approvals related to (if required) related to any object required) related to any object will Management Certificate No comments the object(s) have been obtained? will be obtained as and when be obtained as and when required required Whether all arrangements pertaining to technical Not applicable Management Certificate Not applicable None assistance/collaboration are in operation? Are there any favorable/unfavorable events affecting No Management Certificate Nil None the viability of these object(s)? Is there any other relevant information that may No Management Certificate Nil None Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors materially affect the decision making of the investors? * Chartered Accountant certificate from M/s. P G Bhagwat LLP dated October 15, 2026 #Where material deviation may be defined to mean: a) Deviation in the objects or purposes for which the funds have been raised b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents. 4) Details of objects to be monitored: (i) Cost of objects – Original cost Comments of the Board of Directors Source of information / Revised (as per the Comments of Particulars of - Sr. Item certifications considered Cost Proposed Offer the Monitoring firm No Head by Monitoring Agency for in Rs. Reason for cost revision financing Document) in Agency arrangements preparation of report Crore option Rs. Crore made Phase 2 Factory/Phase No change in Cost. IOD approved, Tree II Building EGM Notice, Management 1 187.00 NA survey and cutting permission NA NA Construction-at certificate, CA Certificate* receive [Showing first 8,000 characters — download PDF for full document]